[10B]-13,17-Bis[(N,N-dicarboxymethyl)carbamoylethyl]-8-{[4-(dihydroxyboranyl)phenyl]prop-2-enylcarbonyl}aminopropyloxyiminoethylidene-3-ethenyl-7-hydroxyl-2,7,12,18-tetramethylporphyrin tetrasodium salt

ID: ALA3120958

Chembl Id: CHEMBL3120958

PubChem CID: 136264456

Max Phase: Preclinical

Molecular Formula: C54H55BN8Na4O15

Molecular Weight: 1070.92

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=Cc1c(C)c2cc3nc(cc4[nH]c(cc5nc(cc1[nH]2)C(C)(O)/C5=C\C=N\OCCCNC(=O)/C=C/c1ccc([10B](O)O)cc1)c(C)c4CCC(=O)N(CC(=O)[O-])CC(=O)[O-])C(CCC(=O)N(CC(=O)[O-])CC(=O)[O-])=C3C.[Na+].[Na+].[Na+].[Na+]

Standard InChI:  InChI=1S/C54H59BN8O15.4Na/c1-6-35-30(2)39-22-40-31(3)36(13-16-48(65)62(26-50(67)68)27-51(69)70)42(58-40)24-43-37(14-17-49(66)63(28-52(71)72)29-53(73)74)32(4)41(59-43)23-45-38(54(5,75)46(61-45)25-44(35)60-39)18-20-57-78-21-7-19-56-47(64)15-10-33-8-11-34(12-9-33)55(76)77;;;;/h6,8-12,15,18,20,22-25,59-60,75-77H,1,7,13-14,16-17,19,21,26-29H2,2-5H3,(H,56,64)(H,67,68)(H,69,70)(H,71,72)(H,73,74);;;;/q;4*+1/p-4/b15-10+,38-18-,39-22-,40-22-,41-23-,42-24-,43-24-,44-25-,45-23-,46-25-,57-20+;;;;/i55-1;;;;

Standard InChI Key:  IFVDPQIAFSPJPH-LSKVZRDOSA-J

Associated Targets(non-human)

Colon 26 (524 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serum (598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Skin (158 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Muscle (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Brain (4203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Lung (1108 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Spleen (906 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kidney (1278 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver (8163 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Tumor (97 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1070.92Molecular Weight (Monoisotopic): 1070.4193AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Asano R, Nagami A, Fukumoto Y, Miura K, Yazama F, Ito H, Sakata I, Tai A..  (2014)  Synthesis and biological evaluation of new boron-containing chlorin derivatives as agents for both photodynamic therapy and boron neutron capture therapy of cancer.,  24  (5): [PMID:24508130] [10.1016/j.bmcl.2014.01.054]

Source